admin – Page 7917 – Get News Story

Balance7: Bringing Hope and Relief to Those Undergoing Chemotherapy This Holiday Season

Balance7 is generously donating 100 gallons of their acclaimed product to those grappling with the side effects of chemotherapy treatments.

In a heartwarming initiative this holiday season, Balance7, in collaboration with Al Siamon and Dr. Nooristani, is reaching out to support individuals undergoing the strenuous journey of chemotherapy. Committed to making a difference, Balance7 is generously donating 100 gallons of their acclaimed product to those grappling with the side effects of chemotherapy treatments.

“During the busy holiday period, it’s easy to overlook health, but it’s the most precious gift one can cherish,” remarks Dr. Nooristani, a respected internal medicine physician and the CEO of Balance7. He emphasizes the transformative impact of Balance7, a product designed to rejuvenate the immune system and help with chemotherapy side effects through its unique alkalinity-based formula.

This special initiative offers hope and much-needed relief to those facing the daunting journey of chemotherapy. Balance7’s success stories are not just claims but are echoed in the heartfelt testimonials of real individuals who have experienced significant improvements in their wellbeing. These inspiring stories of resilience and recovery are available for viewing at Balance7 Testimonials

The holiday season brings more than festive cheer; it brings an opportunity for a free trial of Balance7. However, availability is limited, and interested parties are encouraged to act swiftly to secure their place in this offer. The dedicated team at Balance7 is available from 7 am to 2 pm PST, Monday through Friday, to assist with the process. They can be reached at (800) 793-9039 for a chance to receive this holiday gift of health.

Balance7 is more than a product; it’s a commitment to enhancing the quality of life for those undergoing chemotherapy. While it’s not a cure, it empowers the body and the immune system to defend and recover, as highlighted by Al Siamon.

This season, Balance7 extends its hand in solidarity and support, offering a beacon of hope in the difficult journey of chemotherapy.

Contact: Balance7 Customer Support Phone: (800) 793-9039 Balance7 Official Website

Media Contact
Company Name: Balance7
Contact Person: Holly Davidson
Email: Send Email
Phone: (800) 793-9039
City: Santa Maria
State: CA
Country: United States
Website: www.balance7.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Balance7: Bringing Hope and Relief to Those Undergoing Chemotherapy This Holiday Season

5ire and GRO Initiative Form Strategic Partnership to Pioneer Sustainable Blockchain Solutions

In a stride towards combating global sustainability issues, 5ire, a dual-chain blockchain ecosystem focusing on in-consensus sustainability, has officially joined forces with GRO Initiative, a social-impact organisation dedicated to sustainable livelihood projects and reforestation. This strategic collaboration marks a commitment to become key innovators towards the UN Sustainable Development Goals (SDG) and the Digital Carbon Markets (DCM).

The collaboration between 5ire and GRO Initiative is a significant step beyond a mere alliance; it’s a shared vision to redefine the landscape of Digital Carbon Markets. Together, they aim to set new global standards within the carbon markets, establishing a practical benchmark for responsible and sustainable business practices.

Premium Carbon Offsets for a Greener Tomorrow

The partnership extends to the supply of 5ire’s Carbon Marketplace with GRO’s assets, injecting sustainability into the core of trading. This dynamic synergy ensures that every transaction contributes towards a greener and more sustainable future. Beyond short-term gains, the collaboration commits to a long-term wholesale supply of premium carbon offsets for the 5ire carbon market, making every user an active participant in global efforts to combat climate change.

Innovative RWA Solutions for a Carbon-Neutral World

The collaboration explores asset-backed carbon finance and investment solutions, propelling the financial sector into a new era of on-chain sustainable Real World Assets (RWA). This forward-thinking approach facilitates financial growth and contributes significantly to global efforts for a carbon-neutral future. 5ireChain, 5ire’s native blockchain platform, will provide greater liquidity to a highly fragmented voluntary carbon market, allowing companies to actively trade and retire carbon credits to offset emissions.

Shared Values, Common Goals

The collaboration extends beyond business, encompassing joint marketing, PR, and event strategies linking 5ire to GRO’s impact projects globally. This strategic alignment aims to create awareness and actively involve the community in the journey towards sustainable development.

At the core of this collaboration are shared values and common goals. Both 5ire and GRO Initiative are committed to fostering innovation to address the UN’s Sustainable Development Goals. This collaboration is a testament to their dedication to leveraging technology for positive environmental and social impacts.

About 5ire

5ire is a dual-chain (EVM and WASM) blockchain ecosystem that focuses on combatting global sustainability issues, aligning to the UN’s 2030 agenda for sustainable development. At the core of 5ireChain (5ire’s native blockchain) is a SPoS (Sustainable Proof-of-Stake) consensus mechanism that incentivises validators towards sustainability to receive higher rewards. 5ire aims to bring a paradigm shift from a for-profit to a for-benefit. 5ire’s goal is to combine blockchain with sustainability, whilst onboarding governments’, enterprises’ and institutions’ activities and reporting, related to sustainability-focused real-world assets (RWA).

About GRO Foundation

The GRO Foundation and its GRO Initiative is a social-impact organization dedicated to planting 1 billion trees and creating sustainable livelihood projects, connecting grassroots communities to the global carbon market.

For media inquiries, contact: press@5ire.org

Website: www.5ire.org

Media Contact
Company Name: 5IRE
Contact Person: Utkarsh Amitabh
Email: Send Email
Country: India
Website: www.5ire.org

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: 5ire and GRO Initiative Form Strategic Partnership to Pioneer Sustainable Blockchain Solutions

Mangoceuticals, Inc. (MGRX) Expands Reach: Launches New Hair Growth Product ‘Grow’ and Strengthens Presence in Latin America with MangoRx Mexico

““This has enormous implications for our growth trajectory going forward for several important reasons,” noted Jacob Cohen, MGRX Co-Founder and CEO. “First, ED medications…are available to consumers OTC in Mexico. That presents increased margin and sales volume potential for what we already produce and market here in the USA. Second, Mexico is a completely untapped market as our research indicates that we will be the only company offering an ED product in a flavored rapid-dissolve tablet…””

MangoRx (MGRX) is focused on developing a variety of men’s health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men’s wellness telemedicine services and products as a growing sector and especially related to the area of ED and hair growth

Mangoceuticals, Inc. (NASDAQ: MGRX), through its subsidiary MangoRx Mexico, is targeting the ED market in Mexico and Latin America, a region with an untapped potential for ED medications. This strategic move, facilitated by Diaz Reus International Law Firm, aims to leverage the over-the-counter availability of other ED drugs. With the introduction of their unique flavored rapid-dissolve tablet, MangoRx seems to be poised to capture a significant share of this market.

Manufacturing and Distribution: Laying the Foundation

The company’s focus now is on establishing strong manufacturing partnerships and gaining certification with COFEPRIS. These steps are crucial for securing a robust distribution network, aiming to reach over 40,000 pharmacies and retail outlets. This expansion is not a sudden pivot but a well-planned strategy, initiated in May 2023, to cement their presence in a market with a potential size of USD $216 million for ED pharmaceutical products.

International Recognition and Growth

Achieving COFEPRIS certification is not just a ticket to the Mexican market but also paves the way for expansion into other Latin American countries where ED medications are sold over the counter. This includes Columbia, Ecuador, El Salvador, Chile, Costa Rica, and Panama, significantly broadening MangoRx’s international footprint.

Innovative Partnership with TRYBE Labs

In a parallel strategic move, MangoRx has teamed up with TRYBE Labs to provide FDA-approved at-home blood collection devices and testing services. This collaboration aligns with the company’s commitment to innovative and convenient healthcare solutions, further enhancing its product lines that require physician-reviewed blood tests.

Affiliate Marketing and Consumer Empowerment

TRYBE Labs, with its focus on men’s health, also joins MangoRx as an affiliate marketing partner, aiming to boost the visibility and sales of MangoRx’s wellness products. This partnership emphasizes the importance of accessible healthcare and addresses the stigma often associated with men’s health issues.

Continued Expansion: MangoRx’s Product Line Diversification

Mangoceuticals, Inc. (MGRX) has further diversified its product line with the introduction of ‘Grow,’ a hair growth treatment. This addition complements their existing ED drug, ‘Mango.’ ‘Grow’ is a unique combination of Minoxidil, Finasteride, Vitamin D3, and Biotin, formulated into chewable, mint-flavored tablets. This innovative approach aligns with MangoRx’s philosophy of convenience and efficiency, avoiding the drawbacks of topical treatments.

Innovative Hair Growth Treatment: A Breakthrough in Men’s Wellness

The launch of ‘Grow’ marks a significant step in MangoRx’s mission to provide innovative health solutions. This custom-compounded treatment is designed to tackle male pattern baldness by promoting follicle development and preventing hair loss. The combination of clinically proven ingredients offers a promising solution for hair regrowth, emphasizing MangoRx’s commitment to evolving and performance-driven products.

Medical Endorsement and Clinical Efficacy

Dr. Douglas Christianson, ND, an advisory board member of MangoRx, endorses ‘Grow’ for its evidence-based approach to hair restoration. The product’s clinical efficacy in fostering hair regrowth and enhancing hair health makes it a medically sound choice for individuals addressing hair loss.

Addressing a Widespread Concern

With a significant portion of American men experiencing hair loss at an early age, ‘Grow’ responds to a widespread need for effective treatment. MangoRx’s telemedicine platform facilitates easy access to this treatment, with physician-reviewed prescriptions and discreet delivery.

MangoRx’s expansion into hair growth treatments, alongside its innovative ED products and strategic partnerships, showcases a holistic approach to men’s health and wellness. This comprehensive strategy, combined with their commitment to innovation and accessibility, positions MangoRx as a potential frontrunner in the healthcare sector. For traders and investors, MangoRx’s diverse product range and market expansion potentially represent a compelling opportunity for growth in the evolving healthcare market.

Watch the video below to learn more about MGRX:

Video Link: https://www.youtube.com/embed/lwVd2mKbG9s

MGRX is currently trading closer to its 52 week low (52 Week Range: $0.4200 – $4.3700). Considering the recent press releases and developments taking place at MGRX, there seems to be a significant upside potential for this NASDAQ stock. As always, conduct your own due diligence and follow traders vigilance.

In Monday morning’s session, several penny stocks showed notable activity. Sirius XM Holdings Inc. (SIRI) saw a 6.79% increase at $4.955 with 11.64M shares traded. Gaotu Techedu Inc. (GOTU) rose 7.79% to $2.975, with 5.52M shares changing hands. Innoviz Technologies Ltd. (INVZ) jumped 16.11% to $2.09 with a volume of 15.69M shares. Bluebird bio, Inc. (BLUE) increased by 8.70% to $3.1089, trading 21.55M shares. Meta Materials Inc. (MMAT) saw a smaller gain of 2.30% at $0.0668 with 7.07M shares traded. These movements highlight the dynamic nature of penny stocks in the market

Sources:

https://finance.yahoo.com/news/mangoceuticals-launches-mangorx-mexico-subsidiary-130000423.html

https://finance.yahoo.com/news/mangoceuticals-selects-trybe-labs-nationwide-133000517.html

https://finance.yahoo.com/news/mangoceuticals-expands-mens-health-product-133000245.html

https://www.businessresearchinsights.com/market-reports/hair-growth-treatment-product-market-103000

Disclaimer: FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully read and comprehend our disclaimer found at https://investorbrandmedia.com/disclaimer/. InvestorBrandMedia.com has been compensated five thousand dollars by a 3rd party Bullzeyemedia LLC for advertisement and content distribution services on MGRX for 12/02/2023 to 12/31/2023. We own zero shares of MGRX. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. This article may contain forward-looking statements as defined under Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. These statements, often incorporating terms like “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or similar expressions about future performance or conduct, are based on present expectations, estimates, and projections, and are not historical facts. They carry various risks and uncertainties that may result in significant deviation from the anticipated results or events. Past performance does not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public SEC filings made by the profiled companies at https://www.sec.gov/edgar/searchedgar/companysearch. It is always important to conduct thorough due diligence and exercise caution in trading.InvestorBrandMedia.com is not managed by a licensed broker, a dealer, or a registered investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects, anticipates, estimates, believes, or understands certain actions to possibly occur are not historical facts and may be forward-looking statements. These statements are based on expectations, estimates, and projections that could cause actual results to differ greatly from those anticipated. Investing in micro-cap and growth securities is speculative and entails a high degree of risk, potentially leading to a total or substantial loss of investment. Please note that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by InvestorBrandMedia.com or any third-party service provider to buy or sell securities or other financial instruments. The content in this article does not address the circumstances of any specific individual or entity and does not constitute professional and/or financial advice. InvestorBrandMedia.com is not a fiduciary by virtue of any person’s use of or access to this content.

Media Contact
Company Name: Investor Brand Media
Contact Person: Ash K
Email: investorbrandmedia@gmail.com
Phone: (954) 593-5597
Country: United States
Website: https://investorbrandmedia.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mangoceuticals, Inc. (MGRX) Expands Reach: Launches New Hair Growth Product \’Grow\’ and Strengthens Presence in Latin America with MangoRx Mexico

Stallion Uranium (STLNF) Secures Key Permit for Groundbreaking Coffer Project in Saskatchewan’s Athabasca Basin

The uranium mining sector is poised for significant growth, driven by the global shift towards cleaner energy sources and nuclear power’s increasing role in this transition. Renewed interest in nuclear energy, fueled by environmental policies aimed at reducing carbon emissions and growing investments in nuclear technology, is placing uranium at the forefront. Additionally, geopolitical tensions and supply chain disruptions highlight the need for stable uranium supplies.

The sector’s growth is further bolstered by high-profile investments, such as the collaboration between Bill Gates and Warren Buffett to build a new nuclear reactor in Wyoming. This project, highlighting the interest of influential investors in nuclear energy, could further increase the demand for uranium, making uranium mining companies attractive for investors in the changing energy landscape.

One small cap company in the uranium mining sector that we would like to draw your attention to is Stallion Uranium Corp (TSX-V: STUD; OTCQB: STLNF; FSE: HM40).

Stallion Uranium (STUD) is working to Fuel the Future with Uranium through the exploration of over 3,000 sq/km in the Athabasca Basin, home to the largest high-grade uranium deposits in the world. The company holds the largest contiguous project in the Western Athabasca Basin adjacent to multiple high-grade discovery zones. The leadership and advisory teams at STUD are comprised of uranium and precious metals exploration experts with the capital markets experience and the technical talent for acquiring and exploring early-stage properties. Further, Stallion offers optionality with two gold projects in Idaho and Nevada that neighbour world class gold deposits offering exposure to upside potential from district advancement with limited capital expenditures.

In a recent press release, STUD announced it has received the necessary permits from the Saskatchewan Government to conduct ground-based geophysical surveys and diamond drilling exploration work on its 100% owned Coffer (“Coffer” or the “Project”) Uranium Project in the Athabasca Basin, Saskatchewan.

Highlights

The company is planning for a targeted ground geophysics survey to commence in the coming weeks that will further inform the planned maiden diamond drill program in Q1/2024.
Permitted activities include access trail construction, temporary camp establishment, geophysical surveying, and diamond drilling.
Permits are valid until Nov 1, 2026, allowing for multiple seasons of geophysical surveying and drill testing.

“We are thrilled to share the news that Stallion has secured an exploration permit for our Coffer project in the Athabasca Basin,” stated Drew Zimmerman, CEO of Stallion Uranium. “This permit represents a key step in our ability to continue to advance our high-potential uranium targets. The Southwestern Athabasca Basin is an underexplored corner of the globally recognized Athabasca Basin and we are eager to advance our exploration activities in this burgeoning region that holds the potential to host the next significant uranium discovery.”

Next Steps

Stallion will initiate a targeted geophysical survey in the coming weeks over the Appaloosa Target on the Coffer Project. Further information on the survey and target area will be released in the coming weeks.

About Coffer Project

The Coffer Project comprises 8 mineral claims and covering 35,875 hectares of highly prospective ground in the Western Athabasca Basin. The project has never been drill tested and contains several kilometer-scale prospective zones within the key target areas identified as Appaloosa, Clydesdale and Mustang. The Appaloosa target will be the focus of the up-coming exploration programs as the Company has identified gravity and magnetic lows on a conductive corridor known to correlate to alteration that hosts uranium mineralization. The highly prospective target area shares geological analogues to the nearby Shea Creek deposit, home to over 95M lbs. of uranium.

Stallion Uranium Corp. (STUD.V) has a 52 week high of 51 cents and if things go as planned for the company, Stallion Uranium Corp could exhibit a significant upside potential. As always, conduct your own due diligence and follow traders vigilance.

For more information, please visit https://stud.report/

Watch the below video for more information on STLNF/STUD.V

Video Link: https://www.youtube.com/embed/inyI4Osrm9A?si=dNt2LWC4wrkcZHf1

Some of other uranium mining stock to place on top of radar include Uranium Royalty Corp. (NASDAQ:UROY), Energy Fuels Inc. (NYSE:UUUU), Centrus Energy Corp. (NYSE:LEU), NuScale Power Corporation (NYSE:SMR), Ur-Energy Inc. (NYSE:URG), Denison Mines Corp. (NYSE:DNN), Sibanye Stillwater Limited (NASDAQ:SBSW), NexGen Energy Ltd. (NYSE:NXE), BHP Group Limited (NYSE:BHP), and Cameco Corporation (NYSE:CCJ).

Sources:

https://finance.yahoo.com/news/stallion-uranium-receives-exploration-permit-110000408.html

STUD

https://nypost.com/2021/06/04/bill-gates-warren-buffett-building-nuclear-reactor-in-wyoming/

Disclaimer: FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully read and comprehend our disclaimer found at https://JournalTranscript.com/disclaimer/. JournalTranscript.com has been compensated four thousand dollars by a 3rd party Khaos Media LLC for advertisement and content distribution services on STUD for 12/11/2023 to 12/31/2023. We own zero shares of STUD. JournalTranscript.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of JournalTranscript.com is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. This article may contain forward-looking statements as defined under Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. These statements, often incorporating terms like “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or similar expressions about future performance or conduct, are based on present expectations, estimates, and projections, and are not historical facts. They carry various risks and uncertainties that may result in significant deviation from the anticipated results or events. Past performance does not guarantee future results.JournalTranscript.com does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public SEC filings made by the profiled companies at https://www.sec.gov/edgar/searchedgar/companysearch. It is always important to conduct thorough due diligence and exercise caution in trading.JournalTranscript.com is not managed by a licensed broker, a dealer, or a registered investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects, anticipates, estimates, believes, or understands certain actions to possibly occur are not historical facts and may be forward-looking statements. These statements are based on expectations, estimates, and projections that could cause actual results to differ greatly from those anticipated. Investing in micro-cap and growth securities is speculative and entails a high degree of risk, potentially leading to a total or substantial loss of investment. Please note that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by JournalTranscript.com or any third-party service provider to buy or sell securities or other financial instruments. The content in this article does not address the circumstances of any specific individual or entity and does not constitute professional and/or financial advice. JournalTranscript.com is not a fiduciary by virtue of any person’s use of or access to this content.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stallion Uranium (STLNF) Secures Key Permit for Groundbreaking Coffer Project in Saskatchewan\’s Athabasca Basin

Nano-Cap Notable News Watchlist (ORHB, BCNN, IFUS, DTGI)

In the quest for market catalysts, investors eye potential drivers of stock movements. Among these, news emerges as a formidable force, influencing prices and creating opportunities. Positive news, in particular, has the capability to propel stocks to new heights. Let’s explore four stocks with promising catalysts.

In a remarkable stride towards global expansion, HippoFi, Inc.(OTC: ORHB)‘s subsidiary, PUR Biologics, has made significant inroads into the international market, projecting sales to soar beyond $20 million in the upcoming year.

The biotechnology enterprise reached a new level of success with the breakthrough, which was announced in a press release on December 11, 2023. The breakthrough culminated in a year filled with remarkable accomplishments as the company successfully shipped products for use internationally. The company attributes this triumph to the concerted efforts of a robust distribution network comprising 250 distributors and over 300 sales representatives.

CJ Wiggins, Executive Chairman and CEO of HippoFi, acknowledged the dedication of the distribution network, underscoring the company’s exceptional growth over the last 12 months. “Combining our team of business and scientific experts, global partners, and best-in-class technologies with our world-class distribution network has established PUR as the ‘Authority in Spinal Biologics,'” remarked Wiggins.

The strategic move aligns with PUR Biologics’ aim to capitalize on the burgeoning market for spine surgeries utilizing biological implants, estimated to be worth $3.5 billion annually, with 1.62 million surgeries performed each year. Wiggins is optimistic about the company’s trajectory, expressing confidence in strong sales growth for 2024. “Our business is primed for strong sales growth in 2024 and is expected to track over $20 million,” he affirmed.

Wiggins highlighted the pivotal role of technology in their success, particularly the recent acquisition of the activeOrb technology from ZIMMER BIOMET. This strategic move positions HippoFi to secure a more substantial share of the $3.5 billion opportunity related to bone-growth solutions, further solidifying its standing in the dynamic healthcare market.

In conclusion, the recent international foray and optimistic projections underscore HippoFi’s commitment to pioneering biotech and AI technologies, enhancing patient outcomes, and positioning itself as a frontrunner in the ever-evolving landscape of healthcare innovation.

Balincan USA Inc. (OTC: BCNN), an alternative reporting publicly held company, witnessed an impressive 130% increase in its stock price on Monday. This surge coincides with the release of a significant press update providing insights into Balincan and Tekumo’s outstanding Q4 and 2023 milestones.

In the first two months of the quarter, the company reported a record-breaking revenue of $850K, showcasing a remarkable 516% growth over the corresponding period last year. This achievement surpasses the forecasted $5 million annualized run rate, highlighting the success of Tekumo as an industry-leading service delivery platform.

Phillip Dignan, President and CFO of Balincan, emphasized Tekumo’s pivotal role in reducing costs and time for customers through the management of onsite installation and maintenance of technology systems using on-demand local technicians. The financial update further revealed positive changes to the net loss to common shareholders and a reduction in derivative liability, showcasing the company’s commitment to financial transparency.

In addition to its financial successes, Balincan announced strategic corporate moves, filing for a name and symbol change to Tekumo, Inc. (TKMO), subject to FINRA approval. The filing of a Regulation 1-A offering statement with the SEC signals the company’s intent for follow-on financing to fuel continued growth. With the increase in authorized common shares to $5 billion, the company is strategically positioned for expansion.

In the realm of health and wellness, Impact Fusion International Inc. (OTC: IFUS) has emerged as a distinctive player, marketing proprietary products globally to promote well-being for humans and animals. Beyond the unconventional, the company’s recent updates underscore a proactive and impactful journey.

Impact Fusion International (OTC: IFUS) experienced a notable uptick on December 11, surging to 0.081 USD, reflecting a remarkable 17.05% increase. This surge aligns with IFUS’s strategic efforts in the “Health and Wellness” sector, where they aim to invent, develop, and market innovative products.

IFUS provided a thorough year-end update that detailed the company’s response to the drought conditions that have affected several southern states. IFUS introduced SGP+, an innovative solution with potential applications in enhancing herd health, reducing emissions, eliminating fly infestations, and cutting costs for ranchers. The company actively engages with government officials and key decision-makers to promote the adoption of their technology.

Recent achievements include securing orders from a large feedlot in East Texas and a dairy in Louisiana. According to CEO Marc Walther, a dedicated sales team has been appointed to represent IFUS at industry events and conventions. Furthermore, the company is exploring opportunities in India with positive conversations and a letter of intent from AgriGlow Biotech.

Impact Fusion obtained a USDA permit to import bagasse harvested in India for testing, with results expected in late February–early March 2024. A member of the team volunteers to relocate to India, emphasizing the team’s dedication to project success. Additionally, the company conducted an “Economic Viability Footprint” study, projecting potential replication in sugarcane-growing areas worldwide.

Digerati Technologies, Inc. (OTC: DTGI) recently reported robust financial results for the twelve months ended July 31, 2023, showcasing a significant growth trajectory. The company, specializing in Unified Communications as a Service (UCaaS) solutions for small to medium-sized businesses, experienced a 31% increase in revenue, reaching an impressive $31.6 million compared to $24.15 million in the prior year.

The key financial highlights include a 37% surge in gross profit to $20.34 million, resulting in an improved gross margin of 64.3% compared to 61.3%. Non-GAAP adjusted EBITDA income witnessed a remarkable 50% increase to $4.77 million, reflecting the company’s effective operational strategies and financial performance.

Digerati Technologies successfully streamlined its operations through the consolidation of subsidiaries into a single operating entity, Verve Cloud, Inc. This consolidation, coupled with the integration of acquisitions such as Skynet and NextLevel Internet, contributed to the significant growth in cloud software and service revenue.

Despite one-time, non-recurring costs of $2.55 million related to a terminated transaction with Minority Equal Opportunity Acquisition Corp., Digerati Technologies remains optimistic about its financial stability. The company continues to seek new strategic partnerships and complementary relationships, demonstrating its commitment to sustained growth.

The positive financial metrics, including increased revenue, gross profit, and adjusted EBITDA income, reflect the successful execution of Digerati Technologies’ business strategy. With a solid foundation in place, the company aims to capitalize on organic and inorganic growth opportunities in the cloud services market.

It’s essential to note that Digerati Technologies is actively pursuing strategic initiatives and looks forward to updating shareholders on its progress in the coming months. As the company serves nearly 4,700 business customers and approximately 50,000 users, predominantly in Florida, Texas, and California, it is well-positioned for continued success in the UCaaS sector

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance that are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by HippoFi Inc. to assist in the production and distribution of content related to ORHB. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

Media Contact
Company Name: Capital Gains Report
Contact Person: Mark McKelvie
Email: Send Email
City: NAPLES
State: FLORIDA
Country: United States
Website: https://capitalgainsreport.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Nano-Cap Notable News Watchlist (ORHB, BCNN, IFUS, DTGI)

GPO Plus, Inc. Growth Pace Accelerates, Launches Mission To Expand Retail Presence In Eligible Yesway And Allsup Locations ($GPOX)

GPO Plus, Inc. (OTCQB: GPOX) stock may present a value investment opportunity that is too good to ignore. Yes, that’s a decidedly bullish sentiment. However, it’s supported by tangible evidence showing that GPOX continues to expand its revenue-generating footprint to make its retail presence more pronounced and, importantly, from a valuation perspective, can lead to another breaking of previously set performance records.

Contributing to that presumption is a deal made with hemp smokables company Hempacco Co, Inc. (NASDAQ: HPCO) that can expedite GPOX capitalizing on an estimated $1 trillion industry. And it’s expected to get even bigger, with consumer preference trends showing increasing interest in hemp-based products that offer a satisfying alternative to nicotine tobacco. The deal, which GPOX said will be facilitated through its distribution division Distro+, will promote, market, and sell Hempacco’s entire portfolio of hemp products in Yesway and Allsup’s stores across the United States. That’s no small opportunity.

Yesway is one of the fastest-growing convenience store operators in the United States. The better news is that the deal strengthens GPOX’s previously announced retail partnership, where it highlighted plans to introduce The Feel Good Shop+ in eligible Yesway and Allsup locations. The Feel Good Shop+ is an innovative “store within a store” retail concept offering an extensive range of CBD and other hemp-derived products. GPOX revenues could get a quick boost, especially with GPOX placing popular Hempacco products, including The Real Stuff Hemp Smokables, Rick Ross’s Hemp Hop Smokables and Wraps, Cheech & Chong Smokables and Wraps, and Snoops Dogg’s Dogg lbs brands.

Growth By The Numbers

If so, they will add to recent record-setting operating performance. GPOX announced the best-ever revenues in its 1Q for FY/2024 of $970,735, beating its forecast by roughly 12% and crushing the prior quarter’s revenues by 126%. That performance followed the over 320% sequential revenue growth. GPOX reporting FY/Q4 revenues of $430,000 represented an over 320% increase compared to the three months ending April 30, 2023. Revenues aren’t the only things getting larger.

The store count is as well. GPOX is now operating over 570 locations in several states, a number expected to increase to 1,000 by the end of its current fiscal year. There’s more good news. The average revenue contributions per location is surging, evidenced by the sales from the first 100 stores receiving the new “White Glove Direct Store Delivery” service offered through GPOX’s Distro+ division, soaring over 365% from $580 per location to $2,120. That growth is being met with a GPOX service model and infrastructure that is more efficient than ever, resulting from creating what the company calls a Mini-hub business model, a hub and spoke design that leverages low-cost efficiencies to generate high store revenues.

In particular, GPOX is realizing benefits through its mentioned “White Glove DSD,” a hands-on, full-service business model that GPOX said has been an integral part of driving average sales per unit to record levels. That makes sense. The hands-on service approach facilitates enhanced product offering and allows GPOX to maximize the intrinsic value of its in-store concept, “the Feel Good Shop+,” which offers customers CBD-inspired health and wellness products. Moreover, the GPOX team presence is leading to a potential windfall of revenue-generating opportunities by being on-site to provide clients with a service and benefit that others don’t- primarily filling a product manufacturing and delivery gap for the 15% – 20% of items not typically provided by primary vendors. Technology enhancements are fueling the back end of that opportunity.

GPOX announced live testing, implementation, and the rollout phase for MSRP+, its proprietary software empowering order management, logistics optimization, lead generation, sales analytics, accounting, inventory management, and e-commerce for DISTRO+. Those enable a strategy that maximizes intrinsic strengths, particularly those related to manufacturing and distributing consumer products, fitting well into the GPOX strategy to increase convenience store and specialty retailer client count.

Attracting Clients Through Service

So far, GPOX has said that the service is leading many of its retail partners to ask what additional products can be provided through this uncomplicated and comprehensive GPOX service solution. That’s helped GPOX model for significant near-term growth, saying its combined service differences should contribute to opening at least 500 new locations in its fiscal year. Even better from an investor’s perspective is that by utilizing proprietary technology, real-time data, and efficiencies from its hub and spoke business services model, GPOX revenues from new and existing sites could fall faster toward the bottom line. And there could be plenty more of it to drop.

GPOX believes increased product offerings could increase average sales per convenience store location to over $3,000, about 40% higher than current. Contributing to that cause, GPOX highlighted executing its plans to introduce proprietary new products, such as Yuenglings Ice Cream flavored gummies and High-Cloud gummies, expected to generate roughly 40% gross margins. The gross margins for general products are also impressive, typically between 20% – 35%. Strength in both should accelerate GPOX reaching cash-flow and/or bottom-line EPS, potentially by the end of this new fiscal year. They should get additional help.

GPOX said it expects to onboard roughly 258 new locations in Texas, Iowa, and Kansas by the end of this year and another 123 locations throughout New Mexico in early 2024. With plans to serve the entire product line at each site, using a store-average sales estimate should add appreciably to near-term revenue streams. It could increase further from its mission to fill a service gap. According to GPOX, most retailers get about 80% – 85% of their products from just a few distributors, with the remaining products sometimes represented by dozens of separate vendors.

As one might expect, that’s a significant pain point for most corporate retailers, especially gas stations and convenience stores that sell potentially thousands of different products. For management, it’s a tall order to handle. It’s where GPOX intends to shine by using its White Glove DSD service to mitigate specialty retailers’ challenges of identifying and qualifying new products, ensuring quality, and managing delivery. In the best case, GPOX believes its White Glove DSD service can help to eliminate 100% of the challenges faced, a stat that is doing more than attracting new business; it’s contributing enormously to the growth of serviced locations by simplifying and optimizing client operations.

A Growth Mission In Progress

That could lead to an already impressive growth trajectory to steepen. That’s likely from GPOX’s offering to do the heavy lifting for clients, including price negotiation, meeting minimum order requirements from large manufacturers, and providing uncompromising, hands-on service, from order placement to shelf stocking to end-sales management. Recent quarterly performance shows that that strategy is shifting GPOX’s growth pace from hyperspeed to warp.

The only thing lacking, which is not necessarily bad for investors since it exposes opportunity, is for the share price to follow that lead. By all measures, they should. GPOX is posting consecutive record-setting operating performance, is appreciably growing its retail presence with top-tier clients, and has simplified operations to make revenues more impactful to its bottom line.

In other words, the disconnect between the GPOX share price and the groundwork laid, completed, and pending may be worth seizing. In fact, with GPOX better positioned today than when it scored its 52-week high of $0.29, about 81% higher than current, doing so sooner rather than later may be the best course of action.

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of GPO Plus, Inc. (Nasdaq: GPOX). Primetime Profiles Direct, a property of Shore Thing Media Group, Llc. is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities. In an effort to enhance public awareness, Shore Thing Media Group, Llc. was retained by Spyder Growth Strategies, Llc to create and distribute digital content for GPO Plus, Inc. Spyder Growth Strategies Llc compensated Shore Thing Media Group, Llc., and/or, its parent company, $5,000 to complete and distribute these services. This advertisement is being disseminated for a period of one month beginning on 12/4/23 and ending on 12/31/23. Shore Thing Media Group, Llc. owners, officers, principals, affiliates, contributors, and/or related parties do not own, intend to own, sell, or intend to sell GPO Plus, Inc. stock. However, it is prudent to expect that those hiring Shore Thing Media Group, Llc, including its owners, employees, and affiliates may sell some or even all of the GPO Plus, Inc. shares that they own, if any, during and/or after this engagement period. If successful, this advertisement will increase investor and market awareness of GPO Plus, Inc. and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement does not purport to provide a complete analysis of GPO Plus, Inc. or its financial position. The agency providing this content are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about GPO Plus, Inc. Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in GPO Plus, Inc. SEC filings. Investing in microcap securities such as GPO Plus, Inc. is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, Shore Thing Media Group, Llc. cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains forward-looking statements, including statements regarding expected continual growth of GPO Plus, Inc. and/or its industry. Shore Thing Media Group, Llc. note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect GPO Plus, Inc. actual results of operations. Factors that could cause actual results to vary include the size and growth of the market for GPO Plus, Inc. products and/or services, the company’s ability to fund its capital requirements in the near term and long term, federal and state regulatory issues, pricing pressures, etc. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. Shore Thing Media Group, Llc. are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks. Additional disclosures and disclosures can be found at https://primetimeprofiles.com/disclaimer/.

Media Contact
Company Name: STM, LLC.
Contact Person: Michael Thomas
Email: contact@primetimeprofiles.com
Country: United States
Website: https://primetimeprofiles.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: GPO Plus, Inc. Growth Pace Accelerates, Launches Mission To Expand Retail Presence In Eligible Yesway And Allsup Locations ($GPOX)

Silanes Market Forecasted to Reach USD 3.9 Billion by 2027, at a CAGR of 6.2%

“Browse 286 market data Tables and 50 Figures spread through 284 Pages and in-depth TOC on “Silanes Market””

Silanes Market by Type (Functional Silanes, Mono/Chloro Silanes), Application (Rubber & Plastics, Fiber Treatment, Adhesive & Sealants), End-Use (Building & Construction, Electrical & Electronics, Automotive), And Region

The global Silanes market size is approximated to be USD 2.9 billion in 2022, and it is projected to reach USD 3.9 billion by 2027 at a CAGR of 6.2%. Silanes, also known as silicon hydrides, are compounds formed by covalent bonds between hydrogen and silica. Silanes are manufactured by reacting magnesium silicide with acids or by reducing silicon chlorides with lithium aluminum hydride. Silanes mainly function as coupling agents and surface modifiers. They are available in two types: functional and non-functional groups. The ability of functional silanes to react with inorganic and organic materials and that of non-functional with inorganic materials makes them useful in applications such as crosslinking agents, adhesion promoters, surface modifiers, coupling agents, and dispersing agents. Silanes act as an important part of the rubber & plastics sector, especially the tire industry. The major applications of silanes also include fiber treatment, adhesives & sealants, and paints & coatings.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=202415042

The demand for silanes is mainly furnished by three major sectors that is rubber & plastics, fiber treatment and adhesive & sealants. Some of the leading companies involved in the manufacturing of silanes are Evonik Industries (Germany), Shin-Etsu Chemical Co. Ltd (Japan), Momentive Performance Materials Holdings LLC (US), Dow Inc. (US), Wacker Chemie AG (Germany), Gelest Inc. (US), China National BlueStar (Group) Co. Ltd. (China), WD Silicone Co. Ltd. (China), Jingzhou Jianghan Fine Chemical Co. Ltd. (China), and Nanjing Shuguang Chemical Group Co. Ltd. (China).

Evonik Industries (Germany), deals in various segments, such as smart materials, specialty additives, nutrition & care, performance materials, and technology & infrastructure. The company’s smart materials has covered the largest market share. The company manufactures and sells silanes through the smart materials business segment. The company’s inorganic materials & coatings business unit manufactures silanes and serves various end-use industries such as electronics, construction, tire, and fiber optics.

Shin-Etsu Chemical Co. Ltd (Japan), operates through four business segments — infrastructure materials, electronics materials, functional materials, and processing & specialized services. The company manufactures silanes through the functional materials segment. Functional materials segment. Company manufacture silanes, which find use in a wide range of applications, ranging from thermosetting resins, primers, and paints to electronics and resin modifiers. It has a presence in Japan, Europe, Asia-Pacific, South America, and North America.

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=202415042

Momentive Performance Materials Holdings LLC (US), engages in the production and commercialization of silanes. It operates business through two subsidiaries, namely, Momentive Specialty Chemicals and Momentive Performance Materials Inc. The company develops and manufactures silicones, ceramic materials, and fused quartz. The company offers silanes, specialty silicones, and urethane additives to serve end-use industries such as building & construction, automotive, aerospace, electronics, and medical.

Read Our Trending Press Release Below:

Flow Chemistry Market– Global Forecast to 2028

Electrical Conduit Market – Global Forecast to 2026

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/silanes-market-202415042.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Silanes Market Forecasted to Reach USD 3.9 Billion by 2027, at a CAGR of 6.2%

CVD Lab-Grown Diamonds Market Set to Reach $15.9 Billion by 2027

“Browse 275 market data Tables and 47 Figures spread through 226 Pages and in-depth TOC on “CVD Lab-grown Diamonds Market””

CVD Lab-grown Diamonds Market by Type (Rough, Polished), Color, Application (Machine & Cutting Tools; Heat Sinks & Exchangers; Optical, Laser, & X-ray; Electronics; Healthcare Instruments; Gemstone), and Region – Global Forecast to 2027

The CVD lab-grown diamond market is projected to grow from USD 11.3 billion in 2022 to USD 15.9 billion by 2027, at a CAGR of 7.1% from 2022 to 2027. The growth of the market is driven by the rising awareness and demand for lab-grown diamonds in various industrial applications such as machine & cutting tools, heat sinks & exchangers, and electronics, among others.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=11040749

Companies such as De Beers Group (UK), Sumitomo Electric Industries Ltd. (Japan), Bhanderi Lab Grown Diamonds LLP (India), Hebei Plasma Diamond Technology Co., Ltd. (China), and SP3 Diamond Technologies (US) fall under the winners’ category. These are leading players in the CVD lab-grown diamond market, globally. These players have adopted the strategies of new product launch, acquisitions, and agreements to fulfill the rising demand for CVD lab-grown diamonds on the regional as well as global levels.

De Beers Group is one of the leading diamond firms. The company has manufacturing units in China, Ireland, Germany, South Africa, and the UK. In 2000, the synthetic diamond and tungsten carbide supermaterials business of De Beers Group was rebranded as Element Six. The Company Produces CVD diamonds for aerospace, electronics, and optical applications. In 2020, the company launched the Diafilm ETC700 CVD diamond heat spreader which is designed to provide electrical conductivity in addition to the diamond’s exceptional thermal performance.

SP3 Diamond Technology is a US-based CVD diamond manufacturer. The company produces CVD diamonds for water & wastewater treatment, bio-electrochemical, and electro-synthesis, among other applications. The company also manufactures CVD diamond-coated cutting tools, wears, seals, wafers, and other products. In January 2021, MAPAL signed a agreement with sp3 Diamond Technology for the supply of diamond coatings required for their tools.

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=11040749

Goldiam International Ltd. is an OEM partner and exporter of diamond jewelry. The company offers rough and polished diamonds for jewelry application. The company operates in two segments such as jewelry manufacturing and investment activity. In June 2021, Goldiam International Ltd. acquired an 88% stake in Eco-Friendly Diamonds LLP, a CVD lab-grown diamond manufacturer.

Read Our Trending Press Release Below:

Phenolic Resin Market – Global Forecast to 2026

Polyolefin Pipes Market – Global Forecast to 2026

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: CVD Lab-Grown Diamonds Market Set to Reach $15.9 Billion by 2027

Microballoons.com Introduces Premium Microballoons with Silane-Coated Glass Microspheres for Enhanced End Products

Microballoons.com, innovatively founded by Michael Mcamis of SacPig Bait Co., proudly announces the exclusive introduction of its Premium Glass Microballoons – Silane-Coated. This innovative product, born from relentless research and development, represents a substantial leap forward for companies and makers who incorporate microspheres into a wide spectrum of products, hobbies, and creative endeavors.

Speaking to the media, Michael Mcamis shares his enthusiasm: “Our initial quest was to enhance bait making, but it unexpectedly led us to discover these extraordinary microballoons. Our extensive R&D not only unearthed but also refined these microballoons, revealing their immense potential for a wide range of applications.”

Distinguishing Features of Microballoons.com’s Microballoons:

Versatility: These glass microspheres are exceptionally adaptable, ideal for applications ranging from crafting resin baits and building hobby models to commercial products.
Integration: Easily compatible with existing systems like Alumilite or System 3, requiring minimal adjustments for optimal performance.
Performance: These microballoons deliver superior structural integrity, hardness, and strength. They also enhance ease of sanding and offer an improved screw bite.
Innovative Coating: The silane coating is a significant innovation, strengthening the bond between resin and microballoons for a more durable and robust end product.

Michael Mcamis stresses the importance of this innovation: “The silane coating transcends conventional bonding techniques. It’s about crafting a resilient and enduring end product.”

The Role of Silane Coupling Agents: Silane coupling agents are key in these glass microballoons, forming sturdy chemical bonds between glass microspheres and various materials, resulting in unparalleled adhesion and durability.

Michael Mcamis highlights the unique attributes of their fresh endeavor: “Our premium glass microballoons are more than just a material; it’s a meticulously developed solution, catering to the diverse requirements of our customers.” This statement encapsulates the philosophy of Microballoons.com, a newly launched brand that builds on the legacy of a domain established over 20 years ago, blending rich history with innovative beginnings.

About Michael Mcamis – CEO of Microballoons.com

Michael Mcamis, CEO of Microballoons.com and a renowned entrepreneur in custom craft lure design at SacPig Bait Co., developed Premium Glass Microballoons – Silane-Coated. Driven by a desire for superior quality, his innovation offers transformative solutions for various applications.

Discover the positive impact of these microballoons by visiting https://microballoons.com

Media Contact
Company Name: Microballoons.com
Contact Person: Olivia Webb
Email: Send Email
City: Sacramento
State: California
Country: United States
Website: microballoons.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microballoons.com Introduces Premium Microballoons with Silane-Coated Glass Microspheres for Enhanced End Products

Kingsman Pest Exterminators Shares Tips for Controlling the Infestation of Common Household Pests

Kingsman Pest Exterminators is a top-rated pest control company. In a recent update, the company shared tips for controlling the infestation of common household pests.

Conroe, TX – In a website post, Kingsman Pest Exterminators shared tips for controlling the infestation of common household pests.

The team noted that termite inspection Conroe is crucial because without it, homeowners may not even be aware of a termite infestation until it’s too late. Termites are known as “silent destroyers” as they cause loss of hundreds of dollars in structural damage before being noticed. By conducting regular termite inspections, homeowners can catch infestations early on and prevent further damage.

The contractors mentioned that cockroaches are a health hazard for households as they can spread diseases, contaminate food, and trigger allergies. Therefore, it is essential to control and prevent cockroach infestations. A clean and clutter-free environment is vital for cockroach control Conroe, as they thrive in dark, damp, and dirty areas. Homeowners should also properly manage their waste and seal any cracks where cockroaches can pass.

Lastly, the experts asserted that mosquito control Conroe is crucial for the sake of both the comfort and health of homeowners. Mosquitoes are not only a nuisance with their itchy bites but can also transmit deadly diseases such as malaria and dengue fever. Eliminating sources of standing water is the most effective way to prevent mosquito breeding. Homeowners should regularly check and empty flower pots, buckets, and other stagnant water sources.

About Kingsman Pest Exterminators

Kingsman Pest Exterminators is a premier pest control company. With years of experience, the certified technicians have the expertise and tools to handle any pest problem. They understand that each infestation is unique and requires a personalized approach. That’s why they strive to provide customized solutions based on the needs of their clients.

Media Contact
Company Name: Kingsman Pest Exterminators
Contact Person: Kyle Stephens
Email: Send Email
Phone: (936) 701-6159
City: Conroe
State: Texas
Country: United States
Website: https://www.kingsmanexterminators.com/